Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
8.08
-0.25 (-2.97%)
Aug 14, 2025, 11:26 AM - Market open
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $9.03 million as of August 14, 2025. Its market cap has decreased by -24.21% in one year.
Market Cap
9.03M
Enterprise Value
7.50M
1-Year Change
-24.21%
Ranking
Category
Stock Price
$8.08
Market Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has decreased from $141.44M to $9.03M, a decrease of -93.61%. That is a compound annual growth rate of -10.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 9.31M | 20.77% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | 99.49M | 217.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 571.86B |
| Johnson & Johnson | 415.05B |
| AbbVie | 350.33B |
| UnitedHealth Group | 236.53B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 227.39B |
| Novo Nordisk | 222.88B |